Rheumatoid arthritis (RA) has long been a puzzle for both doctors and patients.
It’s a condition marked by swelling, pain, and stiffness in the joints, often treated successfully with a range of medications designed to reduce inflammation.
However, about 20% of RA patients find no relief from these treatments, leaving scientists and doctors scratching their heads.
A groundbreaking study has shed new light on this mystery.
Researchers, including Dana Orange from Rockefeller’s Laboratory of Molecular Neuro-oncology, discovered that for a certain group of RA patients, the problem isn’t inflammation at all.
Despite having joints that appear swollen and feel tender, these patients’ discomfort isn’t due to the usual suspects—immune cells attacking the joint tissue. Instead, it’s caused by an unusual growth of sensory neurons in the tissues that pad the joints.
Through examining joint tissue samples from patients who experienced pain without clear signs of inflammation, the research team identified a specific set of 815 genes responsible for this abnormal growth.
These genes seem to rewire the sensory nerves, which could explain why conventional anti-inflammatory drugs do not ease the pain for this subset of patients. This discovery opens up the possibility of new treatment avenues that target these specific genetic pathways.
Rheumatoid arthritis symptoms can be debilitating, affecting daily life and well-being. Typically, the disease triggers a response from the immune system, leading to inflammation in the synovium (the lining of the joints), which results in the classic symptoms of RA.
For most patients, targeting the immune system’s overreaction helps manage these symptoms effectively. Yet, the findings from this study highlight a previously overlooked cause of pain in RA patients—nerve growth driven by fibroblasts, particularly a type known as CD55+ fibroblasts.
These fibroblasts, found in the outer layer of the synovial lining, not only assist in the smooth movement of joints but also play a role in nerve growth.
The study identified the NTN4 gene, which produces Netrin-4, a protein known to guide the development of axons—the long, threadlike parts of nerve cells that transmit signals.
In the lab, exposure to Netrin-4 caused pain receptors to branch out, offering a potential explanation for the pain felt by patients.
Imaging studies further revealed that areas of excessive tissue growth, mistaken for inflammation, were actually dense with new blood vessels intertwined with pain-sensing nerve fibers.
This finding suggests that what feels like inflammation to doctors and patients is, in fact, an overgrowth of tissue and nerve cells.
Looking ahead, the research team plans to explore additional factors that might influence the growth of pain-sensitive neurons and investigate whether different types of sensory nerves are affected.
Their goal is not to eliminate sensation entirely, as sensory nerves play crucial roles in movement and awareness, but to identify more precise treatments for those RA patients who do not benefit from current anti-inflammatory drugs.
This research not only offers hope for more effective treatments for RA but also emphasizes the importance of tailoring medical care to the individual needs of patients, ensuring that they receive the right treatment for their specific condition.
If you care about pain, please read studies about how to manage your back pain, and Krill oil could improve muscle health in older people.
For more information about pain, please see recent studies about how to live pain-free with arthritis, and results showing common native American plant may help reduce diarrhea and pain.
The research findings can be found in Science Translational Medicine.
Copyright © 2024 Knowridge Science Report. All rights reserved.
